ArticleArchives of microbiology2026
Anti-inflammatory and anti-bacterial potentials of Caryota mitis L. leaves extract in urothelial LPS-induced inflammation and UTI pathogens.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among bacterial infections, urinary tract infections (UTIs) remain the most prevalent worldwide and are increasingly challenging to manage due to antibiotic resistance and recurrent inflammation. Caryota mitis L. (C. mitis), locally known as the Fishtail plant, has traditionally been used to treat various disease elements. It has been reported to possess antioxidant, antimicrobial, and anti-inflammatory properties; however, its use in treating UTI-associated pathogens and inflammation remains unexplored. Thus, we aimed to evaluate the anti-inflammatory and antibacterial potential of the methanol extract of C. mitis leaves. GC-MS was initially used for characterisation of C. mitis extract, followed by in-vitro anti-inflammatory (LPS-induced human urinary bladder epithelial T24 cells) and anti-bacterial activity against UTI pathogens (E. coli, K. pneumoniae, Pseudomonas spp., Enterobacter spp., and Proteus mirabilis) was investigated. The C. mitis extract significantly reduces levels of inflammatory cytokines and inhibits all tested uropathogens in a dose-dependent manner. This study highlights C. mitis as a promising adjunct natural therapeutic candidate for managing UTIs.
Indexed as
Identifiers
41831095What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.